Publications by authors named "Emma Hockly"

Claim this Profile
T
The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes.
Ben Woodman, Rachel Butler, Christian Landles, Michelle K Lupton, Jamie Tse, Emma Hockly

Brain Res Bull· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.
Emma Hockly, Jamie Tse, Amy L Barker, Donna L Moolman, Jean-Luc Beunard

Neurobiol Dis· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.
Caroline L Benn, Christian Landles, He Li, Andrew D Strand, Ben Woodman, Emma Hockly

Hum Mol Genet· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization and statistical approaches to therapeutic trials in the R6/2 mouse.
Emma Hockly, Benjamin Woodman, Amarbirpal Mahal, Cathryn M Lewis, Gillian Bates

Brain Res Bull· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?
Gillian P Bates, Emma Hockly

Curr Opin Neurol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minocycline and doxycycline are not beneficial in a model of Huntington's disease.
Donna L Smith, Benjamin Woodman, Amarbirpal Mahal, Kirupa Sathasivam, Shabnam Ghazi-Noori, Emma Hockly

Ann Neurol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease.
Emma Hockly, Victoria M Richon, Benjamin Woodman, Donna L Smith, Xianbo Zhou

Proc Natl Acad Sci U S A· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental enrichment slows disease progression in R6/2 Huntington's disease mice.
Emma Hockly, Patricia M Cordery, Benjamin Woodman, Amarbirpal Mahal, Anton van Dellen

Ann Neurol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis